Predictors of Complete Early Virological Response to Pegylated Interferon and Ribavirin in Egyptian Patients with Chronic Hepatitis C Genotype 4

Journals Menu

Follow SCIRP

ISSN Print: 2164-2648
ISSN Online: 2164-2656
www.scirp.org/journal/aid
E-mail: aid@scirp.org

"Predictors of Complete Early Virological Response to Pegylated Interferon and Ribavirin in Egyptian Patients with Chronic Hepatitis C Genotype 4"
written by Gamal El Din Esmat Gamil, Maissa El Said El Raziky, Rabab Maamoun Salama, Wafaa Ahmed El Akel, Waleed Fouad Fathalah, Dina Ismail Attia,
published by Advances in Infectious Diseases, Vol.3 No.2, 2013

has been cited by the following article(s):

[1]	Predictors of sustained virological response to therapy with pegylated interferon plus ribavirin in hepatitis C virus patients
	2018

[2]	Impact of human cytomegalovirus on the response of chronic hepatitis C virus-infected patients to pegylated interferone and ribavirin combination therapy
	2018

[3]	FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection
	Arab Journal of Gastroenterology, 2016

[4]	Interleukin 28B rs12979860 polymorphism and High serum Gamma-glutamyl transpeptidase activity Predict Non-Virological response to Interferon-alpha …
	2015

[5]	Interleukin 28B rs12979860 polymorphism and High serum Gamma-glutamyl transpeptidase activity Predict Non-Virological response to Interferon-alpha/Ribavirin Combined Therapy in Chronic hepatitis C genotype 4 Egyptian patients
	Int. J. Curr. Microbiol. App. Sci, 2015

Follow SCIRP